Favipiravir as a potent inhibitor of Newcastle disease virus: <i>in ovo</i> efficacy, dose-dependent toxicity, and molecular insights into RNA polymerase inhibition.

Vet World · 2025 · PMC12535442 · PMID 41113231

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Urea: Highly significant increase with treatment (p < 0.001, η 2 = 0.760), with post hoc differences in Groups B, C, and E compared with control.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Favipiravir as a potent inhibitor of Newcastle disease virus: &lt;i&gt;in ovo&lt;/i&gt; efficacy, dose-dependent toxicity, and molecular insights into RNA polymerase inhibition.

The sentences

Favipiravir as a potent inhibitor of Newcastle disease virus: <i>in ovo</i> efficacy, dose-dependent toxicity, and molecular insights into RNA polymerase inhibition.